Literature DB >> 22527146

Effects of rifaximin on bacterial translocation in thioacetamide-induced liver injury in rats.

Murat M M Harputluoglu1, Ulvi Demirel, Mehmet Gul, Ismail Temel, Sule Gursoy, Engin Burak Selcuk, Murat Aladag, Yilmaz Bilgic, Ercan Gunduz, Yuksel Seckin.   

Abstract

Intestinal bacterial overgrowth (IBO) and increased mucosal permeability are suggested to increase bacterial translocation (BT) in liver injury. Rifaximin (RIF) is a minimally absorbed oral antimicrobial agent that restores gut microflora imbalance. The aim of the present study was to investigate the effects of RIF on BT frequency in thioacetamide (TAA)-induced liver injury. Group 1 was the control. In group 2 (TAA), rats received TAA daily for 3 days. In group 3 (TAA + RIF), RIF was commenced on the same day as the first dose of TAA. In group 4 (RIF), rats received only RIF. Ileal aspirate Escherichia coli counts were significantly lower in the TAA + RIF group than in TAA group. There was no difference in BT frequency between the TAA and TAA + RIF groups. Our results suggest that factors such as intestinal barrier dysfunction and impaired host immune shield, apart from IBO, play an important role in BT in this model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527146     DOI: 10.1007/s10753-012-9465-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat.

Authors:  D Adawi; F B Kasravi; G Molin; B Jeppsson
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 2.  Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia.

Authors:  Shuhei Sakaguchi; Shinobu Furusawa
Journal:  FEMS Immunol Med Microbiol       Date:  2006-07

3.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

Authors:  C Guarner; B A Runyon; S Young; M Heck; M Y Sheikh
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

Review 4.  Intestinal endotoxemia as a pathogenetic mechanism in liver failure.

Authors:  De-Wu Han
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine.

Authors:  M A Ortega; M I Torres; M I Fernández; A Rios; A Sánchez-Pozo; A Gil
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock.

Authors:  J M Llovet; R Bartolí; R Planas; B Viñado; J Pérez; E Cabré; J Arnal; I Ojanguren; V Ausina; M A Gassull
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

7.  Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.

Authors:  Stefano Fiorucci; Eleonora Distrutti; Andrea Mencarelli; Miriam Barbanti; Ernesto Palazzini; Antonio Morelli
Journal:  Digestion       Date:  2002       Impact factor: 3.216

8.  Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis.

Authors:  J Vlachogiannakos; A S Saveriadis; N Viazis; I Theodoropoulos; K Foudoulis; S Manolakopoulos; S Raptis; D G Karamanolis
Journal:  Aliment Pharmacol Ther       Date:  2009-02-07       Impact factor: 8.171

9.  Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin.

Authors:  P A van Leeuwen; R W Hong; J D Rounds; M L Rodrick; D Wilmore
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

Review 10.  Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

View more
  6 in total

1.  Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells.

Authors:  Sudhir Kumar; Jiang Wang; Shiva Kumar Shanmukhappa; Chandrashekhar R Gandhi
Journal:  Am J Pathol       Date:  2017-04-13       Impact factor: 4.307

2.  Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats.

Authors:  Chittapon Jantararussamee; Siripa Rodniem; Malai Taweechotipatr; Udomsri Showpittapornchai; Wisuit Pradidarcheep
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

3.  Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.

Authors:  Philipp Lutz; Marijo Parcina; Isabelle Bekeredjian-Ding; Hans Dieter Nischalke; Jacob Nattermann; Tilman Sauerbruch; Achim Hoerauf; Christian P Strassburg; Ulrich Spengler
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

4.  Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.

Authors:  Jun Weng; Xu Han; Fanhong Zeng; Yue Zhang; Lei Feng; Lei Cai; Kangyan Liang; Shusong Liu; Shao Li; Gongbo Fu; Min Zeng; Yi Gao
Journal:  Theranostics       Date:  2021-06-11       Impact factor: 11.556

5.  Protective effect of Lactobacillus salivarius Li01 on thioacetamide-induced acute liver injury and hyperammonaemia.

Authors:  Liya Yang; Xiaoyuan Bian; Wenrui Wu; Longxian Lv; Yating Li; Jianzhong Ye; Xianwan Jiang; Qing Wang; Ding Shi; Daiqiong Fang; Jingjing Wu; Kaicen Wang; Qiangqiang Wang; Jiafeng Xia; Jiaojiao Xie; Yanmeng Lu; Lanjuan Li
Journal:  Microb Biotechnol       Date:  2020-07-11       Impact factor: 5.813

Review 6.  Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease.

Authors:  Jacob W Ballway; Byoung-Joon Song
Journal:  Antioxidants (Basel)       Date:  2021-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.